F
F. Cankat Tulunay
Researcher at Ankara University
Publications - 34
Citations - 915
F. Cankat Tulunay is an academic researcher from Ankara University. The author has contributed to research in topics: Morphine & (+)-Naloxone. The author has an hindex of 13, co-authored 34 publications receiving 887 citations. Previous affiliations of F. Cankat Tulunay include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Reversal of experimental neuropathic pain by T-type calcium channel blockers.
Ahmet Dogrul,Luis R. Gardell,Michael H. Ossipov,F. Cankat Tulunay,Josephine Lai,Frank Porreca +5 more
TL;DR: The data support the view that selective T‐ type calcium channel blockers may have significant potential in the treatment of neuropathic pain states and suggest that T‐type calcium channels may play a role in the expression of the neuropathic state.
Journal ArticleDOI
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
Brian Godman,William H. Shrank,Morten Andersen,Christian Berg,Iain Bishop,Thomas Burkhardt,Kristina Garuoliene,Harald Herholz,Roberta Joppi,Marija Kalaba,Ott Laius,Diane McGinn,Vita Samaluk,Catherine Sermet,Ulrich Schwabe,Inês Teixeira,Lesley Tilson,F. Cankat Tulunay,Vera Vlahović-Palčevski,Kamila Wendykowska,Björn Wettermark,Corinne Zara,Lars L. Gustafsson +22 more
TL;DR: This cross-national study has demonstrated considerable variation in the utilization and expenditure of PPIs and statins across Europe, providing opportunities to further improve prescribing efficiency.
Journal ArticleDOI
Policies to enhance prescribing efficiency in europe: findings and future implications.
Brian Godman,William H. Shrank,Morten Andersen,Christian Berg,Iain Bishop,Thomas Burkhardt,Kristina Garuoliene,Harald Herholz,Roberta Joppi,Marija Kalaba,Ott Laius,Julie Lonsdale,Rickard E. Malmström,Jaana E. Martikainen,Vita Samaluk,Catherine Sermet,Ulrich Schwabe,Inês Teixeira,Lesley Tilson,F. Cankat Tulunay,Vera Vlahović-Palčevski,Kamila Wendykowska,Björn Wettermark,Corinne Zara,Lars L. Gustafsson +24 more
TL;DR: The 4E methodology allows European countries to concisely capture the range of current demand-side measures and plan for the future knowing that initiatives can be additive to further enhance their prescribing efficiency.
Journal ArticleDOI
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Brian Godman,William H. Shrank,Björn Wettermark,Morten Andersen,Iain Bishop,Thomas Burkhardt,Kristina Garuoliene,Marija Kalaba,Ott Laius,Roberta Joppi,Catherine Sermet,Ulrich Schwabe,Inês Teixeira,F. Cankat Tulunay,Kamila Wendykowska,Corinne Zara,Lars L. Gustafsson +16 more
TL;DR: European countries must continue learning from each other to fund increased volumes and new innovative drugs as resource pressures grow and there must continue to be strategies to address concerns with generics when they exist.